Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/1/20 → 9/1/26 |
Funding
- Mayo Clinic (Prot #ACCRU SC-1601 // Prot #ACCRU SC-1601)
- Bristol-Myers Squibb Company (Prot #ACCRU SC-1601 // Prot #ACCRU SC-1601)
Prot #ACCRU SC-1601: A Phase III, Randomized, Controlled, Double-Blind Study Evaluating the Safety of Two Doses of Apixaban for Secondary Prevention of Cancer Related Venous Thrombosis in Subjects Who Have Completed at Least Six Months of Anticoagulation
- Martin, Karlyn A (PD/PI)
Project: Research project